At PassionBio.tech, we don’t just advise companies – we build them.

We support NewCos beyond capital raising by stepping in operationally, assembling leadership teams, and guiding early strategic decisions. Our approach includes interim management, business development, scientific positioning, and investor readiness. Here’s a closer look at one of our recent projects, which exemplifies our model from inception to early validation.

Company: NewCo

Mission: To transform metabolic disease management through a novel class of engineered postbiotics, enabling durable glycemic control via the gut-liver axis.

Stage: Seed

Industry: Microbiome Therapeutics

Market: $10–15B addressable market across type 2 diabetes, NAFLD, and obesity-linked metabolic dysfunction.

Deployment: Seed round to complete in vivo PoC, scale bioprocess to GMP-like quality, and prepare for first partnering discussions.

Email us at agile.advisor@passionbio.tech if:

• You’re interested in venture co-creation or seed-stage co-investment
• You’re building or backing clinical-stage biotech
• You’re engaged in co-developing next-generation biotech companies